Tag: ICER
26
NovemberCost-Effectiveness Analysis: Measuring the Real Value of Generic Drugs
Cost-effectiveness analysis reveals that the biggest savings in generic drugs come not from switching from brand to generic-but from swapping expensive generics for cheaper, equally effective alternatives. Learn how pricing distortions and outdated models are costing billions.
Recent posts
-
8 Aug 2026
Why Some Brand-Name Drugs Have No Generic Alternatives: Patents, Biologics & Market Tactics
-
16 Nov 2025
How to Prevent Medication Errors During Care Transitions and Discharge
-
6 Jul 2026
OTC Cough and Cold Medicine Safety: What You Need to Know for All Ages
-
13 Oct 2025
Acupuncture and Chronic Idiopathic Constipation: Benefits, Evidence, and What to Expect
-
7 Jul 2026
The Future Role of Authorized Generics: Market Outlook & Strategic Shifts